Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.

Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics

Open access
Rabbani, Naila, Xue, Mingzhan, Thornalley, Paul J. · 2016 · Glycoconjugate Journal

Abstract

The reactive dicarbonyl metabolite methylglyoxal (MG) is the precursor of the major quantitative advanced glycation endproducts (AGEs) in physiological systems - arginine-derived hydroimidazolones and deoxyguanosine-derived imidazopurinones. The glyoxalase system in the cytoplasm of cells provides the primary defence against dicarbonyl glycation by catalysing the metabolism of MG and related reactive dicarbonyls. Dicarbonyl stress is the abnormal accumulation of dicarbonyl metabolites leading to increased protein and DNA modification contributing to cell and tissue dysfunction in ageing and disease. It is produced endogenously by increased formation and/or decreased metabolism of dicarbonyl metabolites. Dicarbonyl stress contributes to ageing, disease and activity of cytotoxic chemotherapeutic agents. It contributes to ageing through age-related decline in glyoxalase 1 (Glo-1) activity. Glo-1 has a dual role in cancer as a tumour suppressor protein prior to tumour development and mediator of multi-drug resistance in cancer treatment, implicating dicarbonyl glycation of DNA in carcinogenesis and dicarbonyl-driven cytotoxicity in mechanism of action of anticancer drugs. Glo-1 is a driver of cardiovascular disease, likely through dicarbonyl stress-driven dyslipidemia and vascular cell dysfunction. Dicarbonyl stress is also a contributing mediator of obesity and vascular complications of diabetes. There are also emerging roles in neurological disorders. Glo-1 responds to dicarbonyl stress to enhance cytoprotection at the transcriptional level through stress-responsive increase of Glo-1 expression. Small molecule Glo-1 inducers are in clinical development for improved metabolic, vascular and renal health and Glo-1 inhibitors in preclinical development for multidrug resistant cancer chemotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10719-016-9705-z

Cites

142 of 142 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Biochemistry of dicarbonyl stress. a Metabolism of MG by the glyoxalase system. b Formation of hydroimidazolone MG-H1 from arginine residues. c Formation of imidazopurinone MGdG in DNA. Adduct residue is shown with guanyl base only
Fig. 1 Biochemistry of dicarbonyl stress. a Metabolism of MG by the glyoxalase system. b Formation of hydroimidazolone MG-H1 from arginine residues. c Formation of imidazopurinone MGdG in DNA. Adduct residue is shown with guanyl base onlyCC BY · PubMed Central
Fig. 2 Formation of methylglyoxal, metabolism and glycation of protein and DNA in vivo. Tissue levels of MG and MG-H1 adduct residues in tissues are given for mice. PBMC DNA AGEs are for human subjects and flux of MG metabolised by the glyoxalase system and urinary excretion of MG-H1 free adduct is for healthy adduct humans. Data from [2, 63, 89, 122, 137] and Masania, J, Shafie, A, Rabbani, N and Thornalley, P.J., Unpublished observations
Fig. 2 Formation of methylglyoxal, metabolism and glycation of protein and DNA in vivo. Tissue levels of MG and MG-H1 adduct residues in tissues are given for mice. PBMC DNA AGEs are for human subjects and flux of MG metabolised by the glyoxalase system and urinary excretion of MG-H1 free adduct is for healthy adduct humans. Data from [2, 63, 89, 122, 137] and Masania, J, Shafie, A, Rabbani, N and Thornalley, P.J., Unpublished observationsCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 142 references

Research works printed but not linked: 1

  1. Maessen, D., Brouwers, O., Miyata, T., Stehouwer, C., Schalkwijk, C.: Glyoxalase-1 overexpression reduces body weight and adipokine expression, and improves insulin sensitivity in high-fat diet-induced obese mice. Diabetologia 57, Supplement 1, 713 (2014).

Cited by

See all 169

Metadata

Authors
Rabbani, N., Xue, M., & Thornalley, P. J.
Affiliations
  • University of Warwick (GB)
  • University Hospital Coventry (GB)
Corresponding author
Thornalley, Paul J.
Venue
Glycoconjugate Journal
Published
2016-07-12
Volume
33
Issue
4
Pages
513-525
ISSN
  • 0282-0080 (ISSN-L)
  • 1573-4986
OpenAlex
W2467090882
Cited by
169
References
142
Citations by year
2026: 16 · 2025: 10 · 2024: 14 · 2023: 15 · 2022: 19 · 2021: 20 · 2020: 17 · 2019: 19 · 2018: 8 · 2017: 30 · 2016: 1
FWCI
2.07
Type
journal article
Language
en
Open access
Locations
  • Glycoconjugate Journal (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Warwick Research Archive Portal (University of Warwick) (submittedVersion, cc-by)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Aldose Reductase and Taurine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
Keywords
methylglyoxal, dicarbonyl stress, glyoxalase I, advanced glycation end products, hydroimidazolone, protein glycation, aging, cancer, multidrug resistance, cardiovascular disease, dyslipidemia, obesity, diabetes mellitus, neurological disorders
MeSH terms
Aging, Animals, Humans, Lactoylglutathione Lyase, Neoplasms, Pyruvaldehyde, Vascular Diseases, Glycation End Products, Advanced, Dyslipidemias

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics. https://app.cochat.ai/papers/10.1007/s10719-016-9705-z
The paper
Rabbani, N., Xue, M., & Thornalley, P. J. (2016). Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics. Glycoconjugate Journal. https://doi.org/10.1007/s10719-016-9705-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.